Catalyst Wire Dossier Catalyst Wire Dossier

LACTEOL 340 mg

· Forest Laboratories
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LACTEOL 340 mg, covering 2013-12-30 to 2013-12-30. Get the full timeline:

Most recent: Clinical Trial Update: Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) With LACTEOL® 340 mg [Phase 3]

See pricing